Spero Therapeutics Inc (SPRO)
1.175
-0.02
(-1.26%)
USD |
NASDAQ |
Nov 22, 16:00
1.175
0.00 (0.00%)
After-Hours: 18:31
Spero Therapeutics Price: 1.175 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 21, 2024 | 1.19 | 1.21 | 1.15 | 1.19 | 193487.0 |
| Nov 20, 2024 | 1.14 | 1.22 | 1.13 | 1.20 | 328269.0 |
| Nov 19, 2024 | 1.12 | 1.18 | 1.12 | 1.16 | 289521.0 |
| Nov 18, 2024 | 1.20 | 1.20 | 1.12 | 1.14 | 456262.0 |
| Nov 15, 2024 | 1.25 | 1.250 | 1.17 | 1.18 | 465372.0 |
| Nov 14, 2024 | 1.29 | 1.315 | 1.23 | 1.25 | 321256.0 |
| Nov 13, 2024 | 1.30 | 1.32 | 1.29 | 1.31 | 330040.0 |
| Nov 12, 2024 | 1.33 | 1.34 | 1.29 | 1.32 | 176567.0 |
| Nov 11, 2024 | 1.32 | 1.34 | 1.31 | 1.33 | 208653.0 |
| Nov 08, 2024 | 1.31 | 1.32 | 1.28 | 1.32 | 220602.0 |
| Nov 07, 2024 | 1.30 | 1.33 | 1.284 | 1.31 | 184142.0 |
| Nov 06, 2024 | 1.30 | 1.335 | 1.28 | 1.31 | 197173.0 |
| Nov 05, 2024 | 1.26 | 1.33 | 1.250 | 1.31 | 305965.0 |
| Nov 04, 2024 | 1.16 | 1.30 | 1.14 | 1.29 | 317207.0 |
| Nov 01, 2024 | 1.21 | 1.21 | 1.13 | 1.18 | 841491.0 |
| Oct 31, 2024 | 1.24 | 1.275 | 1.160 | 1.23 | 878063.0 |
| Oct 30, 2024 | 1.04 | 1.30 | 1.01 | 1.29 | 2.284M |
| Oct 29, 2024 | 1.29 | 1.33 | 1.27 | 1.31 | 901117.0 |
| Oct 28, 2024 | 1.31 | 1.32 | 1.280 | 1.29 | 119861.0 |
| Oct 25, 2024 | 1.28 | 1.35 | 1.26 | 1.33 | 491171.0 |
| Oct 24, 2024 | 1.27 | 1.27 | 1.23 | 1.26 | 57588.00 |
| Oct 23, 2024 | 1.27 | 1.270 | 1.255 | 1.26 | 24368.00 |
| Oct 22, 2024 | 1.26 | 1.28 | 1.26 | 1.27 | 26603.00 |
| Oct 21, 2024 | 1.28 | 1.28 | 1.26 | 1.28 | 60561.00 |
| Oct 18, 2024 | 1.29 | 1.30 | 1.28 | 1.28 | 87151.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.6801
Minimum
Aug 02 2022
22.07
Maximum
Dec 28 2020
7.140
Average
2.00
Median
Sep 30 2022
Price Benchmarks
| Arbutus Biopharma Corp | 3.505 |
| Equillium Inc | 0.7306 |
| NovaBay Pharmaceuticals Inc | 0.6855 |
| Palatin Technologies Inc | 0.9589 |
| iBio Inc | 2.64 |
Price Related Metrics
| PE Ratio | 14.69 |
| PS Ratio | 0.7053 |
| PEG Ratio | 0.0210 |
| Price to Book Value | 0.9779 |
| Earnings Yield | 6.81% |
| Market Cap | 64.06M |
| PEGY Ratio | 0.0210 |
| Normalized PE Ratio | 14.69 |